Scientific Reports, 9:880, 1-9. Nature Publishing Group Scientific Reports Scientific Reports, 9(1). NLM (Medline) Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019) Philippens, I H C H M, Wubben, J A, Franke, S K, Hofman, S & Langermans, J A M 2019, ' Involvement of the Red Nucleus in the Compensation of Parkinsonism may Explain why Primates can develop Stable Parkinson’s Disease ', Scientific Reports, vol. 9, 880, pp. 1-9 . https://doi.org/10.1038/s41598-018-37381-1
van Kesteren, R E, Hofman, S, Wubben, J A M, Smit, A B & Philippens, I H C H M 2016, ' Individual and Familial Susceptibility to MPTP in a Common Marmoset Model for Parkinson's Disease ', Neurodegenerative Diseases, vol. 16, no. 5-6, pp. 293-303 . https://doi.org/10.1159/000442574 Neurodegenerative Diseases, 16(5-6), 293-303. S. Karger AG
Neuroscience, 312, 247-259. Elsevier Limited Franke, S K, van Kesteren, R E, Wubben, J A, Hofman, S, Paliukhovich, I, van der Schors, R C, van Nierop, P, Smit, A B & Philippens, I H C H M 2016, ' Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage ', Neuroscience, vol. 312, pp. 247-259 . https://doi.org/10.1016/j.neuroscience.2015.09.065
Philippens, I H C H M, Wubben, J A, Finsen, B & 't Hart, B A 2013, ' Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model ', Journal of Neuroimmune Pharmacology, vol. 8, no. 3, pp. 715-726 . https://doi.org/10.1007/s11481-013-9450-z Journal of neuroimmune pharmacology, 8(3), 715-726. SPRINGER